AusCann Group Holdings Ltd does not have significant operations. Previously, it was engaged in the researches, develops, and commercializes various cannabinoid-derived therapeutic products. The company is headquartered in West Perth, Australia.
Research context
AusCann Group Holdings Ltd appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
AusCann Group Holdings Ltd is currently in a long term downtrend where the price is trading 28.7% below its 200 day moving average.
From a valuation standpoint, the stock is 1121.8% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 16048.4.
Finally, its free cash flow grew by 20.1% to $-2M since the same quarter in the previous year.
Based on the above factors, AusCann Group Holdings Ltd gets an overall score of 1/5.